NO153141C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner.Info
- Publication number
- NO153141C NO153141C NO791220A NO791220A NO153141C NO 153141 C NO153141 C NO 153141C NO 791220 A NO791220 A NO 791220A NO 791220 A NO791220 A NO 791220A NO 153141 C NO153141 C NO 153141C
- Authority
- NO
- Norway
- Prior art keywords
- 5alfa
- oner
- androstan
- aza
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
- C07J33/007—Cyclic thioketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/896,120 US4179453A (en) | 1978-04-13 | 1978-04-13 | Process for preparing 17β-carboxy-5-androsten-3-ones |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO791220L NO791220L (no) | 1979-10-16 |
| NO153141B NO153141B (no) | 1985-10-14 |
| NO153141C true NO153141C (no) | 1986-01-22 |
Family
ID=25405660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO791220A NO153141C (no) | 1978-04-13 | 1979-04-10 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4179453A (pl) |
| AR (7) | AR231991A1 (pl) |
| AT (1) | AT377767B (pl) |
| DK (2) | DK165325C (pl) |
| ES (1) | ES479576A1 (pl) |
| FI (1) | FI67389C (pl) |
| GR (1) | GR68531B (pl) |
| NO (1) | NO153141C (pl) |
| PL (2) | PL223577A1 (pl) |
| PT (1) | PT69451A (pl) |
| YU (1) | YU86879A (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5237061A (en) * | 1988-10-31 | 1993-08-17 | Merck & Co., Inc. | Methods of synthesizing benign prostatic hypertropic agents and their intermediates |
| US4970205A (en) * | 1988-12-23 | 1990-11-13 | Smithkline Beecham Corporation | Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase |
| US4937237A (en) * | 1988-12-23 | 1990-06-26 | Smithkline Beckman Corporation | Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase |
| US5360881A (en) * | 1989-06-14 | 1994-11-01 | Societe Francaise Hoechst | Method of cross-linking ethylene monomers using diallyloxyacetic acid and its basic addition salts as cross-linking agents |
| IE76452B1 (en) | 1990-10-29 | 1997-10-22 | Sankyo Co | Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use |
| FR2724174B1 (fr) * | 1994-09-06 | 1997-01-17 | Roussel Uclaf | Procede de preparation d'un derive steroide 17beta-carboxy et nouveaux intermediaires |
-
1978
- 1978-04-13 US US05/896,120 patent/US4179453A/en not_active Expired - Lifetime
-
1979
- 1979-04-03 GR GR58774A patent/GR68531B/el unknown
- 1979-04-06 PT PT69451A patent/PT69451A/pt not_active IP Right Cessation
- 1979-04-09 AR AR276126A patent/AR231991A1/es active
- 1979-04-10 NO NO791220A patent/NO153141C/no unknown
- 1979-04-11 FI FI791193A patent/FI67389C/fi not_active IP Right Cessation
- 1979-04-11 DK DK152579A patent/DK165325C/da not_active IP Right Cessation
- 1979-04-11 ES ES479576A patent/ES479576A1/es not_active Expired
- 1979-04-12 YU YU00868/79A patent/YU86879A/xx unknown
- 1979-04-12 AT AT0275079A patent/AT377767B/de not_active IP Right Cessation
- 1979-04-13 PL PL22357779A patent/PL223577A1/xx unknown
- 1979-04-13 PL PL1979214881A patent/PL126826B1/pl unknown
-
1980
- 1980-06-25 AR AR80281530A patent/AR241488A1/es active
- 1980-06-25 AR AR281534A patent/AR224011A1/es active
- 1980-06-25 AR AR281533A patent/AR222391A1/es active
- 1980-06-25 AR AR281535A patent/AR228037A1/es active
- 1980-06-25 AR AR281531A patent/AR222390A1/es active
- 1980-06-25 AR AR281532A patent/AR225045A1/es active
-
1992
- 1992-07-15 DK DK092192A patent/DK92192A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR224011A1 (es) | 1981-10-15 |
| DK165325C (da) | 1993-03-29 |
| FI67389C (fi) | 1985-03-11 |
| NO153141B (no) | 1985-10-14 |
| PL223577A1 (pl) | 1981-11-27 |
| AR228037A1 (es) | 1983-01-14 |
| FI791193A (fi) | 1979-10-14 |
| DK165325B (da) | 1992-11-09 |
| PT69451A (en) | 1979-05-01 |
| AT377767B (de) | 1985-04-25 |
| AR241488A1 (es) | 1992-07-31 |
| ATA275079A (de) | 1984-09-15 |
| PL126826B1 (en) | 1983-09-30 |
| FI67389B (fi) | 1984-11-30 |
| AR222390A1 (es) | 1981-05-15 |
| ES479576A1 (es) | 1979-12-01 |
| DK92192D0 (da) | 1992-07-15 |
| YU86879A (en) | 1983-10-31 |
| US4179453A (en) | 1979-12-18 |
| AR225045A1 (es) | 1982-02-15 |
| PL214881A1 (pl) | 1981-12-11 |
| DK92192A (da) | 1992-07-15 |
| GR68531B (pl) | 1982-01-14 |
| AR222391A1 (es) | 1981-05-15 |
| NO791220L (no) | 1979-10-16 |
| AR231991A1 (es) | 1985-04-30 |
| DK152579A (da) | 1979-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO150760C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler. | |
| NO154058C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer. | |
| NO155055C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater. | |
| NO158679C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-penem-3-karboksylsyreforbindelser. | |
| NO792787L (no) | Fremgangsmaate ved fremstilling av antiinflammatorisk aktive 4,5-diaryl-2-nitroimidazoler | |
| NO155774C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater. | |
| NO155290C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme sulfonylurinstoffderivater. | |
| NO794069L (no) | Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater. | |
| NO151588C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater | |
| NO812344L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider. | |
| NO152213C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte benzazepiner | |
| NO810675L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater. | |
| NO153569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater. | |
| NO152007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 7beta-(syn-2-oksyimino-arylacetamido)-3-(sulfoalkyltetrazol-5-yl-tiometyl)-cephem-4-karboksylsyrer | |
| NO157976C (no) | Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider. | |
| NO151239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner | |
| NO781878L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner. | |
| NO152787C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner. | |
| NO156167C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater. | |
| NO158800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater. | |
| NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
| NO152128C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-benzoylfenylacetamider | |
| NO153141C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner. | |
| NO146863C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer | |
| NO151008C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser |